Oct 19,2023

Newel Health Registered a New Interventional Study for Management of Hypertension

Newel Health is aiming to start the multicenter randomized study beginning of November 2023 to investigate the long-term efficacy of the Amicomed Digital Therapeutics Program, compared to Usual Care, in reducing Systolic and Diastolic Blood Pressure in subjects with primary hypertension. Amicomed is a Digital therapeutics service and program for BP management and reduction. The key features of Amicomed include: an automatic, expert system based, finite-machine AI algorithm for assessing the evolution of blood pressure levels; generating and delivering a detailed lifestyle program; and a behavioral strategy embedded into the app to increase adherence and persistence into the program.

CLINICAL STUDY

#mobile app

View Analyst & Ambassador Comments
Go to original news
Oct 05,2023 TOP STORY

Dario Signs National Preferred Partner Agreement with a Top Five National Employee Benefits Consulting Firm

DarioHealth announced a new strategic partnership with a top five national employee benefits consulting firm. Through the preferred partnership agreement, Dario becomes the digital chronic condition management option for the Firm's clients looking to implement a solution to address diabetes, pre-diabetes, hypertension, musculoskeletal and behavioral health needs.

COLLABORATION PARTNERSHIP

#institution

#coaching

#mobile app

View Analyst & Ambassador Comments
Go to original news
Oct 05,2023 TOP STORY

Dario Signs National Preferred Partner Agreement with a Top Five National Employee Benefits Consulting Firm

DarioHealth announced a new strategic partnership with a top five national employee benefits consulting firm. Through the preferred partnership agreement, Dario becomes the digital chronic condition management option for the Firm's clients looking to implement a solution to address diabetes, pre-diabetes, hypertension, musculoskeletal and behavioral health needs.

COLLABORATION PARTNERSHIP

#institution

#dtx

#mobile app

View Analyst & Ambassador Comments
Go to original news
Aug 24,2023

Long-Term Results of a Digital Hypertension Self-Management Program: Retrospective Cohort Study

Digital health programs that incorporate frequent blood pressure (BP) self-monitoring and support for behavior change offer a scalable solution for hypertension management. The study examined the impact of a digital hypertension self-management and lifestyle change support program provided by Omada Health over 12 months. Data were analyzed from a retrospective observational cohort of commercially insured members (n=1117) that started the Omada for Hypertension program between January 1, 2019, and September 30, 2021. At 12 months, all members (including members with controlled and uncontrolled BP at baseline) and those with uncontrolled systolic BP at baseline experienced significant mean reductions in SBP (mean -4.8 mm Hg). Members with uncontrolled systolic BP at baseline also had significant reductions in diastolic blood pressure (-4.7 mm Hg), weight (-6.5 lbs), and BMI (-1.1 kg/m2). Those with controlled Systolic BP at baseline maintained within BP goal range. Additionally, 48% (418/860) of members with uncontrolled BP at baseline experienced enough change in BP to improve their BP category.

CLINICAL STUDY

#virtual care

#cbt

View Analyst & Ambassador Comments
Go to original news
Sep 20,2023

Virgin Pulse Unveils Integrated Digital Therapeutics Suite to Rein in High-Cost Chronic Conditions

Virgin Pulse, the global wellbeing, and navigation company, is expanding its clinical health support with the new VP Transform, a suite of digital therapeutics solutions to proactively address chronic conditions, beginning with prediabetes, blood pressure, and weight management. The new VP Transform is a year-long, evidence-based, behavior change program embedded into the Homebase for Health platform, provided to employers and their people. VP Transform will focus on helping members achieve a clinically significant, sustainable weight while increasing levels of physical activity through a scalable digital therapeutic solution that's already part of their daily wellbeing routine. The company is contracting now for the new suite of solutions, which will be generally available in early 2024 and will initially provide support for prediabetes, weight management, and blood pressure.

PRODUCT

#coaching

#virtual care

View Analyst & Ambassador Comments
Go to original news
Sep 20,2023

Virgin Pulse Unveils Integrated Digital Therapeutics Suite to Rein in High-Cost Chronic Conditions

Virgin Pulse, the global wellbeing, and navigation company, is expanding its clinical health support with the new VP Transform, a suite of digital therapeutics solutions to proactively address chronic conditions, beginning with prediabetes, blood pressure, and weight management. The new VP Transform is a year-long, evidence-based, behavior change program embedded into the Homebase for Health platform, provided to employers and their people. VP Transform will focus on helping members achieve a clinically significant, sustainable weight while increasing levels of physical activity through a scalable digital therapeutic solution that's already part of their daily wellbeing routine. The company is contracting now for the new suite of solutions, which will be generally available in early 2024 and will initially provide support for prediabetes, weight management, and blood pressure.

PRODUCT

#coaching

#virtual care

View Analyst & Ambassador Comments
Go to original news
May 25,2016

Medisafe Presents Results of Six-Month Medication Adherence Improvement Study at ISPOR 2016

Medisafe, the personalized medication management platform with over 2.8 million users, announced today that findings from a scientific study conducted by IMS Health showing Medisafe’s medication adherence benefits will be presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 21st Annual International Meeting in Washington D.C. The study showed that Medisafe users taking cholesterol and hypertension medication had 19.5% and 8.4% higher relative adherence at six months respectively compared to a control group of non-users.

CLINICAL STUDY

#mobile app

View Analyst & Ambassador Comments
Go to original news
Sep 07,2018

Medisafe Hypertension Users Stay on Therapy Two-Thirds Longer than Non-users

Medisafe released data today showing that hypertensive patients on the mobile health app, Medisafe, have a rate of therapy persistence almost 2.5 times or 136 percent that of a matched control cohort over a 12-month period, with the disparity increasing further over time. In the study therapy persistence is defined as the percent of patients who have continued to fill their anti-hypertensive medication, allowing for up to a 60-day refill gap. The control cohort was matched 3:1 to the Medisafe cohort – 12,000 patients in the control compared to 4,000 on Medisafe – with the two groups sharing comparable profiles in regards to demographics, previous time on therapy, and payer mix. Key findings suggested that Mean time on therapy was 10.9 months for app users compared to 6.5 months in control. In May of this year, Medisafe released results revealing that 78 percent of previously non-adherent anti-hypertensive patients improve their medication possession ratio (‘MPR’) by over 20 percent on Medisafe.

PRODUCT

#mobile app

View Analyst & Ambassador Comments
Go to original news
Aug 15,2023 TOP STORY

Dario Partners with PlanSource to Offer Employers Easy Access to Proven Digital Health Solutions

DarioHealth announced a new agreement with PlanSource, a leading provider of cloud-based benefits administration and engagement technology, to offer integrated digital health solutions to more than 5 million consumers. The new agreement makes it easy for employers to select and implement Dario's integrated chronic condition management solutions to employee health benefit plans as part of a curated set of benefit solutions in the PlanSource Partner Marketplace. The integration of Dario's solutions into the PlanSource Marketplace creates a seamless digital pathway for employees to engage in solutions.

COLLABORATION PARTNERSHIP

#institution

#coaching

View Analyst & Ambassador Comments
Go to original news
Aug 15,2023 TOP STORY

Dario Partners with PlanSource to Offer Employers Easy Access to Proven Digital Health Solutions

DarioHealth announced a new agreement with PlanSource, a leading provider of cloud-based benefits administration and engagement technology, to offer integrated digital health solutions to more than 5 million consumers. The new agreement makes it easy for employers to select and implement Dario's integrated chronic condition management solutions to employee health benefit plans as part of a curated set of benefit solutions in the PlanSource Partner Marketplace. The integration of Dario's solutions into the PlanSource Marketplace creates a seamless digital pathway for employees to engage in solutions.

COLLABORATION PARTNERSHIP

#institution

#dtx

#coaching

View Analyst & Ambassador Comments
Go to original news
Subscribe to HYPERTENSION